Already established as cornerstone therapies in diabetes and obesity, GLP-1 receptor agonists have now cracked into the ...

Novo Nordisk stock crashed Friday after the firm's next-generation weight-loss drug missed expectations in a highly anticipated study.

Viking Therapeutics has seen a significant drop, despite positive news and promising GLP-1 drug developments. Find out why ...

And the best part? Eligible customers can sign up for a 30-day free trial and experience the incredible benefits Prime offers without paying a penny upfront. Prime aims to make your life more ...